1-6 of 6
Adrian Bloor, PhD, FRCP, FRCPath
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Ibrutinib and Obinutuzumab in CLL: MRD Responses Sustained for Several Years with Deepest MRD Depletion in Patients with >1 Year Prior Ibrutinib Exposure

Andy C. Rawstron, PhD, Peter Hillmen, MBChB, FRCP, FRCPath, PhD, Shanna Maycock, BSc, MSc, Nichola Webster, Kristian Brock, PhD, Rebecca H. Boucher, BSc, MSc, PhD, Francesca Yates, PhD, Rebecca Jarvis, BSc, Surita Dalal, PhD, Ruth M. de Tute, PhD FRCPath, Paul Moss, MBBS, PhD FRCP, Donald Macdonald, MBChB, MD FRCP, PhD FCRPath, Piers Patten, MD PhD, Christopher Fegan, Andrew Pettitt, MA, MB BChir, PhD MRCP, MRCPath, Christopher P. Fox, MD PhD, Adrian Bloor, PhD FRCP, FRCPath, Oonagh Sheehy, MB BCh BAO, MRCP, FRCPath, Peter Hillmen, MBChB, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 27–28.
https://doi.org/10.1182/blood-2020-136990
Published: 2020
Journal Articles

Continued Long Term Responses to Ibrutinib + Venetoclax Treatment for Relapsed/Refractory CLL in the Blood Cancer UK TAP Clarity Trial

Peter Hillmen, MBChB, FRCP, FRCPath, PhD, Rebecca H. Boucher, BSc, MSc, PhD, Nichola Webster, Surita Dalal, PhD, Kristian Brock, PhD, Francesca Yates, PhD, Chhaya Sankhalpara, Donald Macdonald, MBChB, MD FRCP, PhD FCRPath, Christopher Fegan, Alison McCaig, MBChB, FRCPath, PhD MRCP, Anna Schuh, MD MRCP, PhD, Andrew Pettitt, MA, MB BChir, PhD MRCP, MRCPath, John G. Gribben, MD DSc, FRCP, FRCPath, FMedSci, Piers Patten, MD PhD, Stephen Devereux, PhD FRCP, FRCPath, MRCPath, MB BS, Adrian Bloor, PhD FRCP, FRCPath, Christopher P Fox, PhD FRCPath, MRCP, MBChB, Francesco Forconi, MD PhD FRCPath, Andrew Rawstron, PhD, Peter Hillmen, MBChB, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 17–18.
https://doi.org/10.1182/blood-2020-136960
Published: 2020
Journal Articles

Outcome Of Escherichia Coli (E.coli) Blood Stream Infections (BSI) In Haematology-Oncology Patients- Hematopoetic Stem Cell Transplantation (HSCT) Is Not Associated With Increased Mortality

Zena Salih, MRCP, Felicity Fergusson, MRCP, Andrew Stevens, MBBS, Katalina Balassa, MD, Theingi Yin, MRCP, Kirsty Dodgson, FRCPath, Kaczmarsky Ed, FRCPath, Malcolm Guiver, PhD, Ken Mutton, FRCPath, Mike Dennis, FRCPath, Jim Cavet, FRCPath, Tim Sommervaile, FRCPath, Jo Tomlins, RGN, BN, MSc,, John Murray, RGN, MSc, Adrian Bloor, PhD, FRCP, FRCPath, Samar Kulkarni, MD, MRCP, FRCPath
Journal: Blood
Blood (2013) 122 (21): 5455.
https://doi.org/10.1182/blood.V122.21.5455.5455
Published: 2013
Journal Articles

A Multicenter, Phase IV Observational Study Of Ofatumumab In Chronic Lymphocytic Leukemia (CLL): A European Research Initiative On CLL (ERIC) Study

Carol Moreno, MD, Marco Montillo, MD, Panayiotidis Panayiotis, MD, Adrian Bloor, PhD, FRCP, FRCPath, Jehan Dupuis, MD, Anna Schuh, MD, PhD, Stefan Norin, MD, Christian H Geisler, Peter Hillmen, MB ChB, PhD, Michael Doubek, Prof., Petra Obrtlikova, MD, Luca Laurenti, MD, Stephan Stilgenbauer, MD, Lukas Smolej, MD, PhD, Paolo Ghia, MD, PhD, Florence Cymbalista, MD, PhD, Ulrich Jaeger, Niki Stavroyianni, Patrick Carrington, MD, Hamadi Zouabi, MD, Veronique Leblond, MD, Juan Carlos Gomez, MD, Roberto Marasca, MD, Gerardo Musuraca, MD, PHD, Luigi Rigacci, MD, Lucia Farina, Rossella Paolini, Sarka Pospisilova, Prof., Eva Kimby, MD, Colm Bradley, Emili Montserrat, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 1645.
https://doi.org/10.1182/blood.V122.21.1645.1645
Published: 2013
Journal Articles

Incidence and Risk Factors For Pneumocystis Jirovecii pneumonia (PCP) Following Haematopoetic Stem Cell Transplant (HSCT)

Samar Kulkarni, MD, MRCP, FRCPath, Mike Dennis, FRCPath, Jim Cavet, FRCPath, John Murray, RGN, MSc, Jo Tomlins, RGN, BN, MSc, Zena Salih, MRCP, Martin Scott, MRCP, Katalina Balassa, MD, Malcolm Guiver, PhD, Ken Mutton, FRCPath, Ed Kaczmarsky, FRCPath, David Kay, MSc, Tim Sommerville, FRCPath, Kirsty Dodgson, FRCPath, Sven Armin Sommerfeld, MRCP, Adrian Bloor, PhD, FRCP, FRCPath
Journal: Blood
Blood (2013) 122 (21): 4641.
https://doi.org/10.1182/blood.V122.21.4641.4641
Published: 2013
Journal Articles

Safety and Efficacy Of Lomustine (CCNU) Substituting Carmustine (BCNU) In Conditioning For Autologous Haematopoietic Stem Cell Transplantation In Lymphoma. A Retrospective Analysis Of Two Patient Cohorts Over a Ten Year Period

Sven Armin Sommerfeld, MRCP,, Samar Kulkarni, MD, MRCP, FRCPath, David Kaye, Adrian Bloor, PhD, FRCP, FRCPath
Journal: Blood
Blood (2013) 122 (21): 2127.
https://doi.org/10.1182/blood.V122.21.2127.2127
Published: 2013